US 7,837,610 B2Grant
System for improving diastolic dysfunction
Issue Date:2010-11-23
•20 Claims
•6 Drawing Sheets
Abstract
An elastic structure is introduced percutaneously into the left ventricle and attached to the walls of the ventricle. Over time the structure bonds firmly to the walls via scar tissue formation. The structure helps the ventricle expand and fill with blood during the diastolic period while having little affect on systolic performance. The structure also strengthens the ventricular walls and limits the effects of congestive heart failure, as the maximum expansion of the support structure is limited by flexible or elastic members.
Metadata
Assignee
- Kardium Inc.
Inventors
- Samuel Victor Lichtenstein
- Daniel Gelbart
- William Gelbart
Application Information
Application Number:US 11/497,309
Filing Date:2006-08-02
Priority Date:2006-08-02
Art Unit:3762
Classifications
IPC:
A61N1/00
Patent Drawings (6 sheets)
Description
Field of the Invention
[0001] This application relates to cardiac surgery, and in particular to methods of treating heart failure such as congestive heart failure and diastolic dysfunction by percutaneous surgery.
Background of the Invention
[0002] Diastolic dysfunction (i.e., insufficient expansion of the left ventricle during the diastolic phase) and general deterioration of the left ventricular performance are very common problems, affecting about 5 million people in the US alone. The problems can be triggered by a myocardial infraction or develop slowly over time. More background data on congestive heart failure can be found on the internet at: http://healthlink.mcw.edu/article/928348606.html and many other medical sources.
[0003] Prior art treatment can be classified generally into three methods: surgery to change the shape of the left ventricle, wrapping the heart in an elastic net, or introducing a reinforcing structures via a catheter into the left ventricle. The first two methods require extensive surgery. The prior art minimally invasive or percutaneous procedures such as disclosed by US patent applications 2005/0015109; 2004/0243170; 2004/0249408 and 2006/0025800 addressed the need of strengthening the heart wall to resist remodeling and enlargement due to systolic pressure, but do not improve diastolic expansion to allow better filling of the left ventricle with blood. In many cases prior art methods actually sacrifice diastolic function in exchange for preventing the abnormal enlargement of the left ventricle that often follows myocardial infraction. For example, wrapping the heart in an elastic net will assist systolic action and will limit left ventricle enlargement, but will interfere with diastolic function as it will require more force to expand the left ventricle and stretch the net. The same is true for any rigid internal reinforcement.
Summary of the Invention
[0004] As taught herein a system may assist diastolic function, the system being able to fit through a catheter and be installed percutaneously. The system may also limit the enlargement of the left ventricle, thus solving two major problem of congestive heart failure in a single percutaneous procedure. Further advantages will become clear by studying the disclosure and the drawings.
[0005] An elastic structure is introduced percutaneously into the left ventricle and attached to the walls of the ventricle. Over time the structure bonds firmly to the walls via scar tissue formation. The structure helps the ventricle expand and fill with blood during the diastolic period while having little affect on systolic performance. The structure also strengthens the ventricular walls and limits the effects of congestive heart failure, as the maximum expansion of the support structure is limited by flexible or elastic members.
Brief Description of the Drawings
[0006] FIG. 1 is a cross sectional view of a heart showing an embodiment a cardiac device deployed in a left ventricle of the heart.
[0007] FIG. 2-A is a cross sectional view of the left ventricle of the heart with the device of FIG. 1 still in a catheter.
[0008] FIG. 2-B is a cross sectional view of the left ventricle of the heart after deployment of the device of FIG. 1 therein.
[0009] FIG. 3 is a perspective view of an embodiment of the invention.
[0010] FIG. 4 is a cross sectional view of a left ventricle of a heart showing a device being retrieved therefrom using a catheter.
[0011] FIGS. 5-A , 5-B, 5-C and 5-D show different embodiments of the cardiac device, according to further illustrated embodiments.
Detailed Description of the Invention
[0012] Various embodiments of a cardiac device comprise an elastic structure that it introduced into a left ventricle of a heart and assists diastolic function by gently trying to expand the left ventricle. The elastic force is a small fraction of the force during systolic contraction, thus the device has little effect on the systolic pressure or ejected volume. It is well known that diastolic dysfunction is a major cause of cardiovascular failure, as it is far more common than systolic dysfunction. After some time (weeks to months) scar tissue permanently binds the elastic structure of the device to the ventricular wall. At this point the device also prevents ventricular enlargement, acting as reinforcement to the ventricular wall and limiting the maximum size of the left ventricle. Since the enlargement of the left ventricle as a result of congestive heart failure or infarct is gradual, scar tissue will have a chance to form before full bond strength is required between the elastic structure of the device and the ventricular wall.
[0013] FIG. 1 shows a typical deployment of a cardiac device 4 according to one illustrated embodiment of the invention. Deployment is performed via a catheter 1 inserted through the aorta into a left ventricle 2 of a heart 3. Any method of accessing the left ventricle can be used, such as trans-septal or via the apex of the left ventricle. The catheter size is in the same range as other percutaneous cardiac procedures, using sizes in the range of 18 Fr to 28 Fr (about 6 to 9 mm). The cross section also shows the papillary muscles 5 and device 4.
[0014] FIG. 2-A shows the device 4 still inside catheter 1. Device 4 is held by flexible cable 7 which is used to push the device 4 through the catheter 1, typically via a hemostatic seal outside the body (not shown). Typically a guide wire 11 is used to guide the catheter 1 into the left ventricle 2.
[0015] FIG. 2-B shows the device 4 after deployment in the left ventricle 2 of a heart 3. The device 4 expands elastically to fill the left ventricle 2. Ventricular contractions help embed a number of barbs 8 into a ventricular wall 6. Over time, scar tissue 6′ forms a permanent bond between the device 4 and the ventricular wall 6. The maximum opening of the device 4 is limited not only by the ventricular wall 6 but by flexible cross-members 9 and 10. It is desired to connect members 9 across the device 4 rather than between adjacent arms (as shown by reference numeral 10) as this allows the cross member to clear the papillary muscles, allowing the device 4 to cover a larger part of the left ventricle 2. As seen in FIG. 2B , the papillary muscles 5 can fit between two elastic members of device 4.
[0016] FIG. 3 provides a more detailed view of the device of FIGS. 1 , 2-A and 2-B. The cardiac device 4 has two pairs of elastic arms 4′ and 4″. The arms 4′ and 4″ are equipped with barbs 8 and cross members 9 and 10. The arms 4′ and 4″ can be made from any durable elastic material such Nitinol, spring tempered stainless steel, plated beryllium copper or polymeric material. For added elasticity small loops 12 can be added. At an apex of the device 4 a connector 14, such as a thread, is used for temporary attachment to the flexible cable 7 via a thread 13. Cross members 9 and 10 can be flexible steel cables, polymeric cables, flexible ribbons or similar flexible members. The purpose of members 9 and 10 is to limit the maximum dilation of the ventricle 2 and stop ventricular enlargement (after members 4′ and 4″ bond to ventricle wall 6 by scar tissue 6′).
[0017] The number of flexible members 4′ and 4″ of device 4 and number of cross members 9, 10 can vary, the preferred embodiment having from three to twelve elastic members 9, 10. Cross members 9, 10 can connect adjacent elastic members 4′ and 4″ as members 10 do, or connect opposing members 4′ and 4″ as members 9 do. The arrangement shown in FIG. 3 is desired in order to allow elastic members 4′ and 4″ to extend beyond the papillary muscles 5 without cross members 9 touching the papillary muscles 5 or mitral valve cords (also known as chordae tendineae). Like any spring, the force that elastic members 4′ and 4″ exert on ventricle wall 6 is F=k(x+a), “k” being the spring constant, “a” the preload (amount of spring preload beyond the fully dilated position) and “x” the ventricular wall movement. The spring constant k is selected not to interfere with systolic function while still helping diastolic filling. By the way of example, a total force the ventricular wall 6 is capable of exerting on each one of the elastic members 4′ and 4″ is about 20-30 Nt (about 2-3 Kg) and the average movement during contraction is about 1-2 cm. In order to limit the effect on systolic operation the total force is chosen to be below 10% of systolic force, or about 2 Nt. If a preload of 2 cm is chosen, the spring constant can be calculated from the equation: 2 Nt=k(0.02 m+0.02 m), k=50 Nt/m. The size (i.e., diameter) of wire forming elastic members 4′ and 4″ is determined by the spring constant k. The size is typically in the range of 0.5-1 mm.
[0018] In order to place the device 4 correctly relative to the papillary muscles 5 the orientation of the device 4 inside the left ventricle 6 needs to be known. This can be done by fluoroscopy, ultrasound or by other location methods such as magnetizing elastic members 4′ but not 4″. This creates a north and south pole 15 which can be detected from outside the body by a magnetometer (or even a very sensitive magnetic compass).
[0019] The design of the device 4 allows aborting the deployment at any stage and retrieving the device 4. This is illustrated in FIG. 4 . A flexible cable 7 terminating in a hook 16 is introduced via a catheter 1.
[0020] Cross members 9 are snagged by the hook 16 and the device 4 is pulled back into the catheter 1. If retrieval is desirable the two cross members 9 should be permanently joined at a cross-over point 18. This allows the hook 16 to self-center regardless of the point at which the hook 16 snagged cross members 9 and regardless whether the hook 16 has snagged one or both cross members 9. Obviously the retrieval is much more difficult once scar tissue 6′ has developed.
[0021] FIGS. 5-A through 5-D offer a more detailed close-up view of the construction of the device 4. FIG. 5-A shows the elastic elements 4′ and 4″ of the device 4 made of spring wire, cross members 10 made of thin stainless steel cable and barb 8 made of steel wire spot welded to the remainder of the device 4. If needed, a load spreading structure 17 can be added. The load spreading structure 17 can be made of bent wire, spot welded to remainder of the device 4 as shown, or can take the form of a polymeric strip. The complete device 4 can be coated with an anti-coagulant coating, drug eluting coating or any beneficial coating well known from the art of stents.
[0022] FIG. 5-B shows an alternate illustrated embodiment, cut out from a single sheet of elastic material and bent to shape. This mode of construction particularly advantageous when device 4 is made of Nitinol, as Nitinol is difficult to join. As before, an optional load spreading structure 17 can be added.
[0023] FIG. 5-C shows an embodiment of a device 4 that does not use discrete barbs but providing elastic members 4 with a special surface finish to promote rapid bonding with ventricular wall 6. Some examples of such finishes are: porous surfaces, surfaces coated with biological adhesives, surfaces coated with miniature barbs similar to the well known Velcro® fastener (generically termed hook and loop fastener), growth-promoting drug coating etc. It is known in the art that velour-like finishes promote tissue infiltration and greatly increase bonding strength. Test results are listed in U.S. Pat. No. 4,164,046 hereby incorporated by reference.
[0024] FIG. 5-D shows an embodiment in which the cross members are replaced with a continuous layer of a flexible mesh or flexible hemostatic material 18, such as Dacron fabric. When the layer 18 is hemostatic the device 4 can also seal an aneurysm or puncture in the ventricular wall 6, while still providing the other stated benefits. This is particularly desirable when the ventricular wall 6 is already significantly thinned by enlargement.
[0025] While the examples shown use a catheter 1 to enter the left ventricle 6 via the mitral valve, it is obvious that various other techniques may be employed to deploy the device 4. The device 4 can be installed in the left ventricle 6 also via the aortic valve, by piercing an apex of the left ventricle 6 or by an incision at any convenient point. It can be used percutaneously or during conventional cardiac surgery.
Claims
What is claimed is:
1. A method of treating diastolic dysfunction as well as ventricular enlargement, comprising:
inserting a structure having a plurality of elastic arms physically coupled together proximate one end of the elastic arms and at least one flexible cross-member expansion limiter structure coupled to a respective pair of non-successively adjacent ones of the elastic arms across the structure to limit an expansion of the elastic arms into a left ventricle of a heart; and
positioning the structure such that portions of the elastic arms of the structure when expanded contact respective portions of a wall that forms the left ventricle at locations spaced relatively above a point at which a set of papillary muscles extend from the wall which is spaced relatively above an apex of the left ventricle and a portion of the structure is spaced relatively below the point at which the set of papillary muscles extend from the wall that forms the left ventricle without either the elastic arms or the at least one flexible cross-member expansion limiter structure interfering with the papillary muscles or with a number of chordae tendineae that extend from the papillary muscles, wherein the elastic arms assist an expansion of the left ventricle during a diastolic phase of a cardiac cycle and the expansion limiter structure prevents a ventricular enlargement.
2. The method of claim 1, further comprising:
causing portions of the elastic arms to attach to respective portions of the wall that forms the left ventricle at the locations spaced relatively above the point at which the set of papillary muscles extend from the wall.
3. The method of claim 1, further comprising:
permanently bond the structure to ventricular walls by tissue formation having a bond strength sufficient to resist ventricular enlargement over time.
4. The method of claim 1 wherein inserting the structure includes delivering the structure via a catheter.
5. The method of claim 1, further comprising:
retrieving the structure from the left ventricle via a catheter.
6. The method of claim 1 wherein inserting a structure includes inserting the structure having at least some parts of the structure made of a flexible metal wire.
7. The method of claim 1 wherein inserting a structure includes inserting a structure having at least some parts made of a polymeric material.
8. The method of claim 1 wherein inserting a structure includes inserting a structure which bears a biologically beneficial coating.
9. The method of claim 1, further comprising:
orienting the structure to clear the papillary muscles.
10. The method of claim 1 wherein the structure initially attaches itself to the walls of the left ventricle with sharp barbs.
11. The method of claim 1 wherein the structure initially attaches itself to the walls of the left ventricle by elastic pressure.
12. The method of claim 1 wherein inserting a structure includes inserting the structure having the expansion limiter structure spaced relatively inwardly from a distal end of the elastic arms.
13. A cardiac medical device, comprising:
a plurality of elastic arms physically coupled together, the elastic arms movable between a first configuration in which the medical device is sized to be inserted into a left ventricle of a heart and a second configuration in which the plurality of elastic arms physically engage portions of a wall that forms the left ventricle to assist an expansion of the left ventricle during a diastolic phase of a cardiac cycle; and
at least one flexible cross-member expansion limiter structure coupled to a respective pair of the elastic arms across the structure to limit an expansion of the elastic arms to prevent a ventricular enlargement, wherein the elastic arms of the pair of elastic arms that are coupled by the flexible cross-member are not successively adjacent to one another,
wherein the elastic arms are sized to contact respective portions of the wall at locations spaced relatively above a point at which a set of papillary muscles extend from the wall without either the elastic arms or the at least one expansion limiter structure interfering with the papillary muscles or with a number of chordae tendineae that extend from the papillary muscles and with a portion of the device positioned relatively below the point at which the set of papillary muscles extend from the wall.
14. The cardiac medical device of claim 13 wherein the plurality of elastic arms and the at least one flexible cross-member are configurable to be delivered a catheter.
15. The cardiac medical device of claim 13, further comprising:
a coupling structure that allows the cardiac medical device to be retrieving the structure from the left ventricle via a catheter.
16. The cardiac medical device of claim 13 wherein at least one of the plurality of elastic arms and the at least one flexible cross-member are made of a flexible metal wire.
17. The cardiac medical device of claim 13 wherein at least one of the plurality of elastic arms or the at least one flexible cross-member are made of a polymeric material.
18. The cardiac medical device of claim 13 wherein at least one of the plurality of elastic arms or the at least one flexible cross-member bear a biologically beneficial coating.
19. The cardiac medical device of claim 13 wherein at least one of the plurality of elastic arms includes a sharp barb receivable in the wall.
20. The cardiac medical device of claim 13 wherein the flexible cross-member expansion limiter structure is spaced relatively inwardly from a distal end of the elastic arms.
Patent Citations (242)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| US4041955(A) | 1977-08-01 | Kelly et al. | Applicant |
| US4114202(A) | 1978-09-01 | Roy et al. | Applicant |
| US4164046(A) | 1979-08-01 | Cooley | Applicant |
| US4240441(A) | 1980-12-01 | Khalil | Applicant |
| US4263680(A) | 1981-04-01 | Reul et al. | Applicant |
| US4490859(A) | 1985-01-01 | Black et al. | Applicant |
| US4543090(A) | 1985-09-01 | McCoy | Applicant |
| US4794912(A) | 1989-01-01 | Lia | Applicant |
| US4850957(A) | 1989-07-01 | Summers | Applicant |
| US4890602(A) | 1990-01-01 | Hake | Applicant |
| US4890612(A) | 1990-01-01 | Kensey | Applicant |
| US4893613(A) | 1990-01-01 | Hake | Applicant |
| US4921499(A) | 1990-05-01 | Hoffman et al. | Applicant |
| US5021059(A) | 1991-06-01 | Kensey et al. | Applicant |
| US5047047(A) | 1991-09-01 | Yoon | Applicant |
| US5100418(A) | 1992-03-01 | Yoon et al. | Applicant |
| US5104399(A) | 1992-04-01 | Lazarus | Applicant |
| US5122137(A) | 1992-06-01 | Lennox | Applicant |
| US5192314(A) | 1993-03-01 | Daskalakis | Applicant |
| US5258000(A) | 1993-11-01 | Gianturco | Applicant |
| US5312435(A) | 1994-05-01 | Nash et al. | Applicant |
| US5312439(A) | 1994-05-01 | Loeb | Applicant |
| US5320632(A) | 1994-06-01 | Heidmueller | Applicant |
| US5364408(A) | 1994-11-01 | Gordon | Applicant |
| US5366443(A) | 1994-11-01 | Eggers et al. | Applicant |
| US5366459(A) | 1994-11-01 | Yoon | Applicant |
| US5368601(A) | 1994-11-01 | Sauer et al. | Applicant |
| US5450860(A) | 1995-09-01 | O'Connor | Applicant |
| US5478353(A) | 1995-12-01 | Yoon | Applicant |
| US5531760(A) | 1996-07-01 | Alwafaie | Applicant |
| US5593424(A) | 1997-01-01 | Northrup III | Applicant |
| US5713896(A) | 1998-02-01 | Nardella | Applicant |
| US5716397(A) | 1998-02-01 | Myers | Applicant |
| US5720726(A) | 1998-02-01 | Marcadis et al. | Applicant |
| US5728114(A) | 1998-03-01 | Evans et al. | Applicant |
| US5782861(A) | 1998-07-01 | Cragg et al. | Applicant |
| US5800495(A) | 1998-09-01 | Machek et al. | Applicant |
| US5824066(A) | 1998-10-01 | Gross | Applicant |
| US5836990(A) | 1998-11-01 | Li | Applicant |
| US5865791(A) | 1999-02-01 | Whayne et al. | Applicant |
| US5871505(A) | 1999-02-01 | Adams et al. | Applicant |
| US5919207(A) | 1999-07-01 | Taheri | Applicant |
| US5961440(A) | 1999-10-01 | Schweich et al. | Applicant |
| US5964782(A) | 1999-10-01 | Lafontaine et al. | Applicant |
| US5984950(A) | 1999-11-01 | Cragg et al. | Applicant |
| US6001069(A) | 1999-12-01 | Tachibana et al. | Applicant |
| US6024096(A) | 2000-02-01 | Buckberg | Applicant |
| US6104944(A) | 2000-08-01 | Martinelli | Applicant |
| US6113610(A) | 2000-09-01 | Poncet | Applicant |
| US6132438(A) | 2000-10-01 | Fleischman et al. | Applicant |
| US6203554(B1) | 2001-03-01 | Roberts | Applicant |
| US6210432(B1) | 2001-04-01 | Solem et al. | Applicant |
| US6214032(B1) | 2001-04-01 | Loeb et al. | Applicant |
| US6221103(B1) | 2001-04-01 | Melvin | Applicant |
| US6221104(B1) | 2001-04-01 | Buckberg et al. | Applicant |
| US6241747(B1) | 2001-06-01 | Ruff | Applicant |
| US6248124(B1) | 2001-06-01 | Pedros et al. | Applicant |
| US6258258(B1) | 2001-07-01 | Sartori et al. | Applicant |
| US6287321(B1) | 2001-09-01 | Jang | Applicant |
| US6304769(B1) | 2001-10-01 | Arenson et al. | Applicant |
| US6306135(B1) | 2001-10-01 | Ellman et al. | Applicant |
| US6332864(B1) | 2001-12-01 | Schweich, Jr. et al. | Applicant |
| US6346105(B1) | 2002-02-01 | Tu et al. | Applicant |
| US6358258(B1) | 2002-03-01 | Arcia et al. | Applicant |
| US6360749(B1) | 2002-03-01 | Jayaraman | Applicant |
| US6379366(B1) | 2002-04-01 | Fleischman et al. | Applicant |
| US6391048(B1) | 2002-05-01 | Ginn et al. | Applicant |
| US6391054(B2) | 2002-05-01 | Carpentier et al. | Applicant |
| US6402680(B2) | 2002-06-01 | Mortier et al. | Applicant |
| US6402781(B1) | 2002-06-01 | Langberg et al. | Applicant |
| US6406420(B1) | 2002-06-01 | McCarthy et al. | Applicant |
| US6409760(B1) | 2002-06-01 | Melvin | Applicant |
| US6416459(B1) | 2002-07-01 | Haindl | Applicant |
| US6436052(B1) | 2002-08-01 | Nikolic et al. | Applicant |
| US6450171(B1) | 2002-09-01 | Buckberg et al. | Applicant |
| US6475223(B1) | 2002-11-01 | Werp et al. | Applicant |
| US6485489(B2) | 2002-11-01 | Teirstein et al. | Applicant |
| US6506210(B1) | 2003-01-01 | Kanner | Applicant |
| US6537198(B1) | 2003-03-01 | Vidlund et al. | Applicant |
| US6537314(B2) | 2003-03-01 | Langberg et al. | Applicant |
| US6540670(B1) | 2003-04-01 | Hirata et al. | Applicant |
| US6551312(B2) | 2003-04-01 | Zhang et al. | Applicant |
| US6569160(B1) | 2003-05-01 | Goldin et al. | Applicant |
| US6569198(B1) | 2003-05-01 | Wilson et al. | Applicant |
| US6575971(B2) | 2003-06-01 | Hauck et al. | Applicant |
| US6589208(B2) | 2003-07-01 | Ewers et al. | Applicant |
| US6626930(B1) | 2003-09-01 | Allen et al. | Applicant |
| US6632238(B2) | 2003-10-01 | Ginn et al. | Applicant |
| US6662034(B2) | 2003-12-01 | Segner et al. | Applicant |
| US6723038(B1) | 2004-04-01 | Schroeder et al. | Applicant |
| US6726704(B1) | 2004-04-01 | Loshakove et al. | Applicant |
| US6726716(B2) | 2004-04-01 | Marquez | Applicant |
| US6743241(B2) | 2004-06-01 | Kerr | Applicant |
| US6749622(B2) | 2004-06-01 | McGuckin, Jr. et al. | Applicant |
| US6760616(B2) | 2004-07-01 | Hoey et al. | Applicant |
| US6780197(B2) | 2004-08-01 | Roe et al. | Applicant |
| US6797001(B2) | 2004-09-01 | Mathis et al. | Applicant |
| US6800090(B2) | 2004-10-01 | Alferness et al. | Applicant |
| US6852076(B2) | 2005-02-01 | Nikolic et al. | Applicant |
| US6855143(B2) | 2005-02-01 | Davison et al. | Applicant |
| US6890353(B2) | 2005-05-01 | Cohn et al. | Applicant |
| US6899674(B2) | 2005-05-01 | Viebach et al. | Applicant |
| US6908478(B2) | 2005-06-01 | Alferness et al. | Applicant |
| US6949122(B2) | 2005-09-01 | Adams et al. | Applicant |
| US6960229(B2) | 2005-11-01 | Mathis et al. | Applicant |
| US6986775(B2) | 2006-01-01 | Morales et al. | Applicant |
| US6989028(B2) | 2006-01-01 | Lashinski et al. | Applicant |
| US6994093(B2) | 2006-02-01 | Murphy | Applicant |
| US6997951(B2) | 2006-02-01 | Solem et al. | Applicant |
| US7025776(B1) | 2006-04-01 | Houser et al. | Applicant |
| US7050848(B2) | 2006-05-01 | Hoey et al. | Applicant |
| US7052487(B2) | 2006-05-01 | Cohn et al. | Applicant |
| US7144363(B2) | 2006-12-01 | Pai et al. | Applicant |
| US7177677(B2) | 2007-02-01 | Kaula et al. | Applicant |
| US7186210(B2) | 2007-03-01 | Feld et al. | Applicant |
| US7189202(B2) | 2007-03-01 | Lau et al. | Applicant |
| US7279007(B2) | 2007-10-01 | Nikolic et al. | Applicant |
| US7300435(B2) | 2007-11-01 | Wham et al. | Applicant |
| US7303526(B2) | 2007-12-01 | Sharkey et al. | Applicant |
| US7507252(B2) | 2009-03-01 | Lashinski et al. | Applicant |
| US7513867(B2) | 2009-04-01 | Lichtenstein | Applicant |
| US2001/0003158(A1) | 2001-06-01 | Kensey et al. | Applicant |
| US2001/0005787(A1) | 2001-06-01 | Oz et al. | Applicant |
| US2001/0018611(A1) | 2001-08-01 | Solem et al. | Applicant |
| US2001/0020126(A1) | 2001-09-01 | Swanson et al. | Applicant |
| US2001/0044568(A1) | 2001-11-01 | Langberg et al. | Applicant |
| US2002/0016628(A1) | 2002-02-01 | Langberg et al. | Applicant |
| US2002/0026092(A1) | 2002-02-01 | Buckberg et al. | Applicant |
| US2002/0055775(A1) | 2002-05-01 | Carpentier et al. | Applicant |
| US2002/0087173(A1) | 2002-07-01 | Alferness et al. | Applicant |
| US2002/0115944(A1) | 2002-08-01 | Mendes et al. | Applicant |
| US2002/0161394(A1) | 2002-10-01 | Macoviak et al. | Applicant |
| US2002/0161406(A1) | 2002-10-01 | Silvian | Applicant |
| US2002/0169359(A1) | 2002-11-01 | McCarthy et al. | Applicant |
| US2002/0169360(A1) | 2002-11-01 | Taylor et al. | Applicant |
| US2002/0169504(A1) | 2002-11-01 | Alferness et al. | Applicant |
| US2002/0183836(A1) | 2002-12-01 | Liddicoat et al. | Applicant |
| US2002/0183841(A1) | 2002-12-01 | Cohn et al. | Applicant |
| US2002/0188170(A1) | 2002-12-01 | Santamore et al. | Applicant |
| US2002/0198603(A1) | 2002-12-01 | Buckberg et al. | Applicant |
| US2003/0045896(A1) | 2003-03-01 | Murphy et al. | Examiner |
| US2003/0050682(A1) | 2003-03-01 | Sharkey et al. | Applicant |
| US2003/0050685(A1) | 2003-03-01 | Nikolic et al. | Applicant |
| US2003/0069570(A1) | 2003-04-01 | Witzel et al. | Applicant |
| US2003/0069636(A1) | 2003-04-01 | Solem et al. | Applicant |
| US2003/0078465(A1) | 2003-04-01 | Pai et al. | Applicant |
| US2003/0078671(A1) | 2003-04-01 | Lesniak et al. | Applicant |
| US2003/0105384(A1) | 2003-06-01 | Sharkey et al. | Applicant |
| US2003/0105520(A1) | 2003-06-01 | Alferness et al. | Applicant |
| US2003/0109770(A1) | 2003-06-01 | Sharkey et al. | Applicant |
| US2003/0149333(A1) | 2003-08-01 | Alferness | Applicant |
| US2003/0163191(A1) | 2003-08-01 | Nikolic et al. | Applicant |
| US2003/0220667(A1) | 2003-11-01 | van der Burg et al. | Applicant |
| US2003/0229395(A1) | 2003-12-01 | Cox | Applicant |
| US2004/0002626(A1) | 2004-01-01 | Feld et al. | Applicant |
| US2004/0054279(A1) | 2004-03-01 | Hanley | Applicant |
| US2004/0133273(A1) | 2004-07-01 | Cox | Applicant |
| US2004/0138744(A1) | 2004-07-01 | Lashinski et al. | Applicant |
| US2004/0153146(A1) | 2004-08-01 | Lashinski et al. | Applicant |
| US2004/0158321(A1) | 2004-08-01 | Reuter et al. | Applicant |
| US2004/0186566(A1) | 2004-09-01 | Hindrichs et al. | Applicant |
| US2004/0215232(A1) | 2004-10-01 | Belhe et al. | Applicant |
| US2004/0243170(A1) | 2004-12-01 | Suresh et al. | Applicant |
| US2004/0249408(A1) | 2004-12-01 | Murphy et al. | Applicant |
| US2004/0249453(A1) | 2004-12-01 | Cartledge et al. | Applicant |
| US2004/0267358(A1) | 2004-12-01 | Reitan | Applicant |
| US2005/0004668(A1) | 2005-01-01 | Aklog et al. | Applicant |
| US2005/0015109(A1) | 2005-01-01 | Lichtenstein | Applicant |
| US2005/0054938(A1) | 2005-03-01 | Wehman et al. | Applicant |
| US2005/0055089(A1) | 2005-03-01 | Macoviak et al. | Applicant |
| US2005/0060030(A1) | 2005-03-01 | Lashinski et al. | Applicant |
| US2005/0064665(A1) | 2005-03-01 | Han | Applicant |
| US2005/0080402(A1) | 2005-04-01 | Santamore et al. | Applicant |
| US2005/0096047(A1) | 2005-05-01 | Haberman et al. | Applicant |
| US2005/0107723(A1) | 2005-05-01 | Wehman et al. | Applicant |
| US2005/0107871(A1) | 2005-05-01 | Realyvasquez et al. | Applicant |
| US2005/0125030(A1) | 2005-06-01 | Forsberg et al. | Applicant |
| US2005/0137700(A1) | 2005-06-01 | Spence et al. | Applicant |
| US2005/0149014(A1) | 2005-07-01 | Hauck et al. | Applicant |
| US2005/0149114(A1) | 2005-07-01 | Cartledge et al. | Applicant |
| US2005/0154252(A1) | 2005-07-01 | Sharkey et al. | Applicant |
| US2005/0182365(A1) | 2005-08-01 | Hennemann et al. | Applicant |
| US2005/0187620(A1) | 2005-08-01 | Pai et al. | Applicant |
| US2005/0197692(A1) | 2005-09-01 | Pai et al. | Applicant |
| US2005/0197693(A1) | 2005-09-01 | Pai et al. | Applicant |
| US2005/0197694(A1) | 2005-09-01 | Pai et al. | Applicant |
| US2005/0197716(A1) | 2005-09-01 | Sharkey et al. | Applicant |
| US2005/0209636(A1) | 2005-09-01 | Widomski et al. | Applicant |
| US2005/0216052(A1) | 2005-09-01 | Mazzocchi et al. | Applicant |
| US2005/0216054(A1) | 2005-09-01 | Widomski et al. | Applicant |
| US2005/0240249(A1) | 2005-10-01 | Tu et al. | Applicant |
| US2005/0251116(A1) | 2005-11-01 | Steinke et al. | Applicant |
| US2005/0267574(A1) | 2005-12-01 | Cohn et al. | Applicant |
| US2006/0004424(A1) | 2006-01-01 | Loeb et al. | Applicant |
| US2006/0014998(A1) | 2006-01-01 | Sharkey et al. | Applicant |
| US2006/0015002(A1) | 2006-01-01 | Moaddeb et al. | Applicant |
| US2006/0015003(A1) | 2006-01-01 | Moaddes et al. | Applicant |
| US2006/0015038(A1) | 2006-01-01 | Weymarn-Scharli | Applicant |
| US2006/0025800(A1) | 2006-02-01 | Suresh | Applicant |
| US2006/0030881(A1) | 2006-02-01 | Sharkey et al. | Applicant |
| US2006/0135968(A1) | 2006-06-01 | Schaller | Applicant |
| US2006/0135970(A1) | 2006-06-01 | Schaller | Applicant |
| US2006/0184242(A1) | 2006-08-01 | Lichtenstein | Applicant |
| US2006/0199995(A1) | 2006-09-01 | Vijay | Applicant |
| US2006/0229491(A1) | 2006-10-01 | Sharkey et al. | Applicant |
| US2006/0235286(A1) | 2006-10-01 | Stone et al. | Applicant |
| US2006/0241334(A1) | 2006-10-01 | Dubi et al. | Applicant |
| US2006/0264980(A1) | 2006-11-01 | Khairkhahan et al. | Applicant |
| US2006/0276683(A1) | 2006-12-01 | Feld et al. | Applicant |
| US2006/0281965(A1) | 2006-12-01 | Khairkhahan et al. | Applicant |
| US2006/0293698(A1) | 2006-12-01 | Douk | Applicant |
| US2007/0016068(A1) | 2007-01-01 | Grunwald et al. | Applicant |
| US2007/0118215(A1) | 2007-05-01 | Moaddeb | Applicant |
| US2007/0161846(A1) | 2007-07-01 | Nikolic et al. | Applicant |
| US2007/0198058(A1) | 2007-08-01 | Gelbart et al. | Applicant |
| US2007/0213578(A1) | 2007-09-01 | Khairkhahan et al. | Applicant |
| US2007/0213815(A1) | 2007-09-01 | Khairkhahan et al. | Applicant |
| US2007/0250160(A1) | 2007-10-01 | Rafiee | Applicant |
| US2007/0270688(A1) | 2007-11-01 | Gelbart et al. | Applicant |
| US2008/0004643(A1) | 2008-01-01 | To et al. | Applicant |
| US2008/0004697(A1) | 2008-01-01 | Lichtenstein et al. | Applicant |
| US2008/0045778(A1) | 2008-02-01 | Lichtenstein et al. | Applicant |
| US2008/0071298(A1) | 2008-03-01 | Khairkhahan et al. | Applicant |
| US2008/0086164(A1) | 2008-04-01 | Rowe | Applicant |
| US2009/0192539(A1) | 2009-07-01 | Lichtenstein | Applicant |
| EP2082690(A1) | 2009-07-01 | Applicant | |
| WO90/15582 | 1990-12-01 | Applicant | |
| WO1/78625 | 2001-10-01 | Applicant | |
| WO3/015611 | 2003-02-01 | Applicant | |
| WO3/077800 | 2003-09-01 | Applicant | |
| WO2004012629 | 2004-02-01 | Applicant | |
| WO2004047679 | 2004-06-01 | Applicant | |
| WO2004/084746 | 2004-10-01 | Applicant | |
| WO2004100803 | 2004-11-01 | Applicant | |
| WO2005/046520 | 2005-05-01 | Applicant | |
| WO2005070330 | 2005-08-01 | Applicant | |
| WO2005102181 | 2005-11-01 | Applicant | |
| WO2006017809 | 2006-02-01 | Applicant | |
| WO2006135747 | 2006-12-01 | Applicant | |
| WO2006135749 | 2006-12-01 | Applicant | |
| WO2007021647 | 2007-02-01 | Applicant | |
| WO2007/115390 | 2007-10-01 | Applicant |
Non-Patent Literature (30)
- Sharkey et al., “Left Ventricular Apex Occluder. Description of a Ventricular Partitioning Device,” Euro Intervention 2:125-127, 2006.Applicant
- Otasevic et al., “First-in-Man Implantation of Left Ventricular Partitioning Device in a Patient With Chronic Heart Failure: Twelve-Month Follow-up,” Journal of Cardiac Failure 13(7):517-520, 2007.Applicant
- U.S. Appl. No. 10/690,131, filed Oct. 20, 2003, Lichtenstein.Applicant
- U.S. Appl. No. 12/120,195, filed May 13, 2008, Dahlgren et al.Applicant
- Athanasuleas et al., “Surgical Anterior Ventricular Restoration for Ischemic Cardiomyopathy,” Operative Techniques in Thoracic and Cardiovascular Surgery 7(2):66-75, May 2002.Applicant
- Buchbinder, MD, “Dynamic Mitral Valve Annuloplasty: A Reshapable Ring for Residual and Recurring MR,” from the Foundation for Cardiovascular Medicine, La Jolla, CA. May 24, 2007.Applicant
- CardioSeal Product Brochure, URL=http://nmtmedical.com/products/ci/index.htm, download date: May 13, 2006.Applicant
- Cooley, “Ventricular Aneurysms and Akinesis,” Cleveland Clinic Quarterly 45(1):130-132, 1978.Applicant
- David et al., “Postinfarction Ventricular Septal Rupture: Repair by Endocardial Patch with Infarct Exclusion,” Journal of Thoracic and Cardiovascular Surgery 110(5):1315-1322, 1995.Applicant
- Dor et al., “Left Ventricular Aneurysm: A New Surgical Approach,” Thoracic Cardiovascular Surgery 37:11-19, 1989.Applicant
- Dor et al., “Late Hemodynamic Results After Left Ventricular Patch Repair Associated with Coronary Grafting in Patients with Postinfarction Akinetic or Dyskinetic Aneurysm of the Left Ventricle,” Journal of Thoracic and Cardiovascular Surgery 110(5):1291-1301, 1995.Applicant
- Dor, “Left Ventricular Aneurysms: The Endoventricular Circular Patch Plasty,” Seminars in Thoracic and Cardiovascular Surgery 9(2):123-130, Apr. 1997.Applicant
- Jatene, “Left Ventricular Aneurysmectomy,” Journal of Thoracic and Cardiovascular Surgery 89(3):321-331, 1985.Applicant
- Konings et al., “Development of an Intravascular Impedance Catheter for Detection of Fatty Lesions in Arteries,” IEEE Transactions on Medical Imaging 16(4):439-446, 1997.Applicant
- Mack, “New Techniques for Percutaneous Repair of the Mitral Valve,” Heart Failure Review 11:259-268, 2006.Applicant
- Menicanti et al., “The Dor Procedure: What has Changed After Fifteen Years of Clinical Practice?” Journal of Thoracic and Cardiovascular Surgery 124(5):886-890, Nov. 2002.Applicant
- Rivera et al., “Ventricular Aneurysms and Akinesis,” Cleveland Clinic Quarterly 45(1):133-135, 1978.Applicant
- Stiles et al., “Simulated Characterization of Atherosclerotic Lesions in the Coronary Arteries by Measurement of Bioimpedance,” IEEE Transactions on Biomedical Engineering 50(7):916-921, 2003.Applicant
- Tanaka et al., “Artificial SMA Valve for Treatment of Urinary Incontinence: Upgrading of Valve and Introduction of Transcutaneous Transformer,” Bio-Medical Materials and Engineering 9:97-112, 1999.Applicant
- Timek et al., “Septal-Lateral Annular Cinching (‘SLAC’) Reduces Mitral Annular Size Without Perturbing Normal Annular Dynamics,” Journal of Heart Valve Disease 11(1):2-10, 2002.Applicant
- Timek et al., “Septal-Lateral Annular Cinching Abolishes Acute Ischemic Mitral Regurgitation,” Journal of Thoracic and Cardiovascular Surgery 123(5):881-888, 2002.Applicant
- Torrent-Guasp et al., “Spatial Orientation of the Ventricular Muscle Band and Approach to Partial Ventriculotomy in Heart Failure,” Pathogenesis and Treatment, Ch. 36, pp. 685-693.Applicant
- Valvano et al., “Thermal Conductivity and Diffusivity of Biomaterials Measured with Self-Heated Thermistors,” International Journal of Thermodynamics 6(3):301-311, 1985.Applicant
- Extended European Search Report, mailed Jun. 26, 2008, for EP08100878.1, 11 pages.Applicant
- Lichtenstein, “Methods and Devices for Altering Blood Flow Through the Left Ventricle,” Preliminary Amendment mailed Mar. 6, 2006 for U.S. Appl. No. 10/571,165, 7 pages.Applicant
- Lichtenstein, “Methods and Devices for Altering Blood Flow Through the Left Ventricle,” Office Action mailed Mar. 26, 2007 for U.S. Appl. No. 10/622,129, 17 pages.Applicant
- Lichtenstein, “Methods and Devices for Altering Blood Flow Through the Left Ventricle,” Amendment mailed Jul. 26, 2007 for U.S. Appl. No. 10/622,129, 17 pages.Applicant
- Lichtenstein, “Methods and Devices for Altering Blood Flow Through the Left Ventricle,” Office Action mailed Nov. 14, 2007 for U.S. Appl. No. 10/622,129, 6 pages.Applicant
- Lichtenstein, “Methods and Devices for Altering Blood Flow Through the Left Ventricle,” Preliminary Amendment mailed Feb. 14, 2008 for U.S. Appl. No. 10/622,129, 15 pages.Applicant
- Lichtenstein, “Methods and Devices for Altering Blood Flow Through the Left Ventricle,” Examiner's Amendment mailed Mar. 2, 2009 for U.S. Appl. No. 10/622,129, 5 pages.Applicant